CASE Op-Ed in RealClear Health: Trump, Harris Confront Weighty Issue This Election
For decades, the cost and accessibility of healthcare has been a major issue in federal elections. This year’s race...
Biden Claims Victory as Medical Innovation is Threatened
October 4, 2023 President Biden announced yesterday that the makers of the first 10 drugs selected for so-called Medicare...
The Small Molecule Penalty Mindlessly Pulls the Brake on Medical Innovation
September 13, 2023 (Alexandria, Virginia) — Today Consumer Action for a Strong Economy (CASE), urged the House Committee on...
Biden Administration Gets its Way – American Healthcare Pays the Price
August 29, 2023 Today, the Centers for Medicare & Medicaid Services (CMS) released their list of the first 10...
CASE Op-Ed w/ Jack Kalavritinos in RealClear Policy: AARP is Cheering on the Socialist Left’s Takeover of Our Health System
February 3, 2023 It’s not your grandparents’ AARP anymore. Whether it’s their celebration of the Inflation Reduction Act or historical support of Obamacare,...
CASE Op-Ed in Issues & Insights: Democrats Celebrate Their Delusion Over Healthcare
October 23, 2022 In a desperate attempt to reshape the narrative, President Biden hosted a celebration last month for...
CASE Issues Statement & Letter to Senate on Danger of Democrats’ Latest Drug Pricing Plan
July 21, 2022 Today, Gerard Scimeca, Chairman of Consumer Action for a Strong Economy, issued the following statement and...
CASE Sends Letter to Key House Leaders Urging Passage of Innovative MARCA Legislation
June 9 ,2022 CASE today sent a letter to the Chairpersons and Ranking Members of key House committees urging...
CASE Op-ed – RealClear Health: Innovative, Pro-Patient MARCA Legislation Deserves Congressional Action
April 13, 2022 It would seem that any policy innovation that could lower healthcare costs, expand access, provide better care,...
Biden Administration and Progressive Lawmakers Willing to Sacrifice Seniors’ Health to Push Through Trillions in Partisan Spending
September 9, 2021 The Biden administration recently announced its plan to “lower prescription-drug prices” by way of Medicare negotiation—but...
- 1
- 2
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/